Abstract
Erratum: PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading?
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1097/rlu.0000000000005206
Copy DOIJournal: Clinical nuclear medicine | Publication Date: Mar 7, 2024 |
Erratum: PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading?
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.